BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 16410893)

  • 1. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
    Aquino VR; Lunardi LW; Goldani LZ; Barth AL
    Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
    Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
    PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pathogenesis of candidemia caused by non-albicans Candida species].
    Myoken Y
    Nihon Ishinkin Gakkai Zasshi; 2009; 50(4):225-8. PubMed ID: 19942793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
    Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
    Neufeld PM; Melhem Mde S; Szeszs MW; Ribeiro MD; Amorim Ede L; da Silva M; Lazéra Mdos S
    Braz J Microbiol; 2015 Jun; 46(2):477-84. PubMed ID: 26273262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility].
    França JC; Ribeiro CE; Queiroz-Telles Fd
    Rev Soc Bras Med Trop; 2008; 41(1):23-8. PubMed ID: 18368266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.
    Tan TY; Tan AL; Tee NW; Ng LS
    Ann Acad Med Singap; 2008 Oct; 37(10):835-40. PubMed ID: 19037517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
    Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
    Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.
    Colombo AL; Da Matta D; De Almeida LP; Rosas R
    Braz J Infect Dis; 2002 Jun; 6(3):118-23. PubMed ID: 12144747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
    Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
    Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.